Sperm motility in mice with Oligo-astheno-teratozoospermia restored by in vivo injection and electroporation of naked mRNA

Author:

Vilpreux Charline1,Martinez Guillaume12ORCID,Court Magali1,Appaix Florence3,Duteyrat Jean-Luc4ORCID,Henry Maxime3,Vollaire Julien3,Ayad Camille5,Yavz Altan5,De Macedo Lisa1,Chevalier Geneviève1,Lambert Emeline1,Conte Sekou Ahmed1,Giordani Elsa1,Josserand Véronique3,Brocard Jacques4ORCID,Charles Coutton12ORCID,Verrier Bernard5,Ray Pierre F.16ORCID,Loeuillet Corinne1,Arnoult Christophe1ORCID,Escoffier Jessica1ORCID

Affiliation:

1. Université Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team Genetic, Epigenetic and Therapies of infertility, Institute for Advanced Biosciences 38 000 Grenoble

2. UM de Génétique Chromosomique, Hôpital Couple-Enfant

3. Université Grenoble Alpes

4. Université Claude Bernard Lyon 1

5. Université Claude Bernard Lyon 1 – Laboratoire de Biologie Tissulaire et d’Ingénierie Thérapeutique

6. UM GI-DPI, CHU Grenoble Alpes

Abstract

Oligo-astheno-teratozoospermia (OAT), a recurent cause of male infertility, is the most frequent disorder of spermatogenesis with a probable genetic cause. Patients and mice bearing mutations in the ARMC2 gene have a decreased sperm concentration, and individual sperm show multiple morphological defects and a lack of motility – a canonical OAT phenotype. Intra Cellular Sperm Injection (ICSI) is required to treat such a condition but it has limited efficacy and was associated with a small increase in birth defects. Consequently, new targeted treatments are needed to restore spermatogenesis. Here, a combination of in vivo injection and electroporation of capped and poly-A-tailed naked mRNA is tested as a strategy to treat ARMC2 -related infertility in mouse. mRNAs coding for several reporter genes are tested and the efficiency and the kinetic of expression are assessed using in vivo and in vitro 2D and 3D imaging experiments. We show that mRNA-coded reporter proteins are detected for up to 3 weeks mostly in germ cells, making the use of mRNA possible to treat infertility. We compare these results with those obtained with a more conventional DNA plasmid vector. In contrast, the use of the non-integrative plasmid Enhanced Episomal Vector (EEV) shows low and transient expression in spermatogenic cells. Consequently, injection and electroporation of naked mRNA- Armc2 into the testes of Armc2 -deficient males were performed and we show the presence of normal and motile sperm in the epididymis. This study shows for the first time that mRNA- Armc2 efficiently restores spermatogenesis and opens new paths for male infertility treatment.All procedures involving animals were performed in line with the French guidelines for the use of live animals in scientific investigations. The study protocol was approved by the local ethics committee (ComEth Grenoble #318) and received governmental authorization (ministerial agreement #38109-2022072716142778).

Publisher

eLife Sciences Publications, Ltd

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3